1.1 Evidence on the safety of repetitive short-pulse transscleral cyclophotocoagulation for glaucoma shows no major safety concerns. Evidence on efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website.
1.2 Further research should ideally be in the form of randomised controlled trials comparing the procedure with standard care. It should report details of patient selection, particularly whether the glaucoma is refractory or non-refractory. Outcomes should include duration of effect.